Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0262811
Abstract: Introduction Although patients with severe COVID-19 are known to be at high risk of developing thrombotic events, the effects of anticoagulation (AC) dose and duration on in-hospital mortality in critically ill patients remain poorly understood… read more here.
Keywords: ill patients; critically ill; therapeutic dose; risk ... See more keywords